BETHANY JESSEE: Open Payments
NPI 1336698414 · GUNTERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,141 in 126 payments from 21 companies in 2025. Trend: 2023 $105 · 2024 $1,105 · 2025 $2,141
Food & beverage: $2,141
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $343 |
| AstraZeneca Pharmaceuticals LP | 16 | $330 |
| Novo Nordisk Inc | 19 | $221 |
| Astellas Pharma US Inc | 13 | $185 |
| Lundbeck LLC | 9 | $155 |
| PFIZER INC. | 6 | $120 |
| Lilly USA, LLC | 6 | $112 |
| Phathom Pharmaceuticals, Inc. | 9 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $91 |
| Exact Sciences Corporation | 4 | $74 |
Products named: REXULTI, AIRSUPRA, Veozah, Wegovy, BREZTRI, VOQUEZNA, MOUNJARO, Kerendia.
Industry payments across AL — which companies pay providers there.
